The short version of lyophilized powder fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-11-13 and is reviewed periodically as new material appears.
该分子是经过结构修饰的合成肽,通过脂肪酸侧链与白蛋白结合,从而延长循环时间。皮下给药后,药物逐步释放并分布至组织。降解主要依赖蛋白酶,肾脏清除占次要地位。人体半衰期以天为单位,但准确数值随检测方法和个体差异而变;组织分布与受体占有率仍是开放问题。
临床研究通常测量体重、腰围、空腹血糖、糖化血红蛋白和血脂,并记录不良事件。药代动力学评估关注浓度-时间曲线,药效动力学评估关注代谢标志物变化。体重下降由能量摄入减少、能量消耗变化和脂肪组织重塑共同造成,具体权重仍不明确。研究之间的终点定义和随访时长差异使横向比较复杂。
Laboratory handling follows the conventions used for other synthetic peptides. Lyophilized material is weighed and dissolved in an aqueous diluent, typically sterile water or bacteriostatic water, using gentle swirling rather than vigorous shaking, because foaming stresses the chain. Solutions are prepared under clean conditions and, where sterility matters, passed through a suitable filter. Working portions are kept small so that stock material is not repeatedly warmed and cooled, a practice that limits both aggregation and gradual loss of activity.
Stability depends strongly on physical state. Dry powder is comparatively robust when held at -20 °C or below, desiccated and shielded from light; under those conditions degradation is slow and measured over years. Once dissolved, the peptide becomes far more vulnerable: backbone hydrolysis, oxidation of susceptible residues and aggregation all proceed faster in solution, and the rates climb with temperature and with pH far from neutral. Refrigerated storage at 2–8 °C extends usable life for short periods, and repeated freeze–thaw cycles are best avoided.
| Property | Value | Notes |
|---|---|---|
| 分子量 | 约4.7 kDa | 合成肽,具体数值随形式而变化 |
| 外观 | 白色至类白色冻干粉 | 常见于多肽制剂 |
| 溶解度类别 | 水溶性 | 可溶于水性缓冲液,pH影响溶解 |
| 典型储存温度 | -20°C或更低 | 冻干粉长期保存 |
| 典型分析方法 | 反相高效液相色谱与质谱 | 用于纯度、身份和杂质分析 |
Identification and purity assessment typically rely on reversed-phase high-performance liquid chromatography, often paired with mass spectrometry. Mass measurement confirms the expected molecular mass and can reveal truncations or modifications. Peptide mapping and sequencing techniques provide sequence-level confirmation when needed. Because related peptide impurities can behave similarly in a single method, orthogonal techniques are usually combined. Reported purity values depend heavily on the method used and should be interpreted with that in mind.
Dissolution behavior depends on the amino acid sequence, the counterion content, and the buffer chosen. Many peptides disperse readily in water or mild aqueous buffers, while others require a small amount of organic co-solvent or a change in pH. Adsorption to plastic and glass surfaces can reduce the concentration of a solution over time, particularly at low concentrations. Filtration before analysis removes particulates, and aliquoting limits repeated freeze-thaw cycles that stress the material.
Research-grade peptide material is commonly supplied as a lyophilized powder, a form that limits degradation during transport and storage. Standard practice keeps such material cold and protected from light and moisture, with tighter conditions used for long-term archives. Once dissolved, solutions are generally considered less stable than the dry powder and are handled on shorter timescales. These established conventions derive largely from general peptide chemistry rather than from compound-specific evidence alone.
Several questions remain unresolved. It is not yet known whether the compound reduces cardiovascular events or mortality, because outcome studies require long follow-up. The durability of weight reduction after treatment withdrawal is uncertain, and rebound has been observed with other incretin-based therapies. Long-term safety data covering several years are limited. Effects in adolescents, in pregnancy, and in people with significant kidney or liver impairment have not been characterized in published reports.
Randomized studies of retatrutide measure change in body weight as a percentage of baseline, along with absolute weight loss. Glycemic endpoints include hemoglobin A1c and fasting plasma glucose. Investigators also track blood pressure, lipid fractions, and liver fat content to characterize effects beyond weight alone. Trial designs typically use double-blind, placebo-controlled groups with periodic dose escalation, and they record adverse events throughout both treatment and follow-up periods.
Quantification of the peptide in biological samples generally relies on liquid chromatography coupled with tandem mass spectrometry. This approach separates the analyte from matrix components and detects it by mass-to-charge transitions specific to the molecule. Immunoassays offer higher throughput but can cross-react with related peptides and metabolites, so mass spectrometric methods are preferred when structural confirmation is required. Method validation typically addresses accuracy, precision, selectivity, and stability under handling conditions.
Material handling focuses on limiting degradation. Lyophilized powder is generally stored at reduced temperature, often around minus twenty degrees Celsius, protected from light and moisture. Once dissolved, the peptide is less stable and is commonly kept cold and used within a short window. Repeated freeze-thaw cycles promote aggregation and should be avoided. Buffers and pH influence stability, and solution conditions are usually selected to keep the peptide near neutral pH where degradation proceeds more slowly. These practices apply to laboratory reference material, not to clinical preparations.
Verification of research-grade material depends on documentation supplied with a sample. A certificate of analysis lists purity, identity, and the methods used to establish each value. Buyers comparing suppliers look at chromatographic purity figures, mass confirmation data, and whether methods are described in enough detail to be reproduced. Independent testing can confirm reported values but adds cost and time. Because the research chemical market is not uniformly regulated, provenance and documentation quality vary widely, and claims should be evaluated against raw data rather than summary labels.
==== Pharmacokinetics of indoline derivatives ==== Sunitinib's peak plasma level is reached 6–12 hours post-dose. The drug is 95% protein bound and has a volume of distribution of 2230 L, which indicates distribution into tissues. Sunitinib is metabolised mostly by CYP3A4 and has a half-life of 40–60 hours. Nintedanib reaches maximum plasma concentration 2–4 hours post-dose. The drug is 97,8% protein bound and is preferentially distributed in plasma. Only a minor part of the biotransformation of nintedanib is caused by CYP3A4 as the prevalent metabolic reaction for nintedanib is a hydrolytic cleavage of esterases. The half-life of nintedanib is about 10–15 hours.
=== COVID-19 === In 2021, dimethyl fumarate was evaluated as a treatment for COVID-19 as part of the RECOVERY Trial in the UK. The results of the trial found that dimethyl fumarate did not significantly improve clinical outcomes in hospitalized COVID-19 patients.
==== Neuromuscular and inherited muscle disorders ==== Other conditions that may be confused with polymyositis include amyotrophic lateral sclerosis, chronic spinal muscular atrophy, myasthenia gravis, and inherited metabolic myopathies such as McArdle disease.
Sources: en.wikipedia.org
In this role, she serves as an advocate and liaison for basic science researchers working in clinical departments to help facilitate the combination of “basic research” which seeks to answer fundamental scientific questions and “translational research” that seeks to put those findings to use, for example in a clinical setting. In 2020, she was named director of the department of pharmacology and molecular sciences at Johns Hopkins University School of Medicine, becoming the first African-American director of a basic science department, and the first Black woman to chair any department, at Johns Hopkins University School of Medicine. Outside of Johns Hopkins, Bumpus chaired the National Institute of Health (NIH)'s Xenobiotic and Nutrient Disposition and Action study section and served as a science commissioner and member of Washington, D.C.’s Science Advisory Board. She was an associate editor of the journal Drug Metabolism and Disposition. She has been strongly involved with the American Society for Pharmacology and Experimental Therapeutics (ASPET), where she served as secretary and treasurer and president.
== Proteins which contain the ICK motif == Agouti related peptide Agouti signalling peptide Albumin I Covalitoxin-II DkTx Grammotoxin GsMTx-4 Guangxitoxin Hainantoxin Hanatoxin Heteroscodratoxin-1 Huwentoxin Maurocalcine Theraphosa leblondi toxin δ-Palutoxin Phrixotoxin Psalmotoxin Robustoxin Stromatoxin Tachystatin Vanillotoxin Vejocalcin
Turin, as the former capital of the Kingdom of Sardinia and the Kingdom of Italy, is home of the Savoy Residences. In addition to the 17th-century Royal Palace, built for Madama Reale Christine Marie of France (the official residence of the Savoys until 1865) there are many palaces, residences and castles in the city centre and in the surrounding towns. Turin is home to Palazzo Chiablese, the Royal Armoury, the Royal Library, Palazzo Madama, Palazzo Carignano, Villa della Regina, and the Valentino Castle. The complex of the Residences of the Royal House of Savoy in Turin and in the nearby cities of Rivoli, Moncalieri, Venaria Reale, Agliè, Racconigi, Stupinigi, Pollenzo and Govone was declared a World Heritage Sites by UNESCO in 1997. UNESCO also recognises Turin as a "Design City." In recent years, Turin has become an increasingly popular tourist destination, ranking 203rd in the world and tenth in Italy in 2008, with about 240,000 tourist arrivals. The Egyptian Museum of Turin specialises in archaeology and anthropology, in particular the art of ancient Egypt. It is home to what is regarded as one of the largest collections of Egyptian antiquities outside of Egypt. In 2006 it received more than 500,000 visitors. The Museum of Oriental Art houses one of the most important Asian art collections in Italy. Other museums include the National Museum of Cinema, the Museo Nazionale dell'Automobile, the J-Museum, the Museum of Human Anatomy Luigi Rolando, the Museo delle Marionette (puppet museum) and the Museo Nazionale della Montagna (National Museum of the Mountains).
In May 1952, Raymond Gosling, a graduate student working under the supervision of Rosalind Franklin, took an X-ray diffraction image, labeled as "Photo 51", at high hydration levels of DNA. This photo was given to Watson and Crick by Maurice Wilkins and was critical to their obtaining the correct structure of DNA. Franklin told Crick and Watson that the backbones had to be on the outside. Before then, Linus Pauling, and Watson and Crick, had erroneous models with the chains inside and the bases pointing outwards. Franklin's identification of the space group for DNA crystals proved her correct. In February 1953, Linus Pauling and Robert Corey proposed a model for nucleic acids containing three intertwined chains, with the phosphates near the axis, and the bases on the outside. Watson and Crick completed their model, which is now accepted as the first correct model of the double helix of DNA. On 28 February 1953 Crick interrupted patrons' lunchtime at The Eagle pub in Cambridge, England to announce that he and Watson had "discovered the secret of life".
Sources: en.wikipedia.org
== Use in biotechnology == Keyhole limpet hemocyanin (KLH) is used extensively as a carrier protein in the production of antibodies for research, biotechnology and therapeutic applications. Haptens are substances with a low molecular weight such as peptides, small proteins and drug molecules that are generally not immunogenic and require the aid of a carrier protein to stimulate a response from the immune system in the form of antibody production. KLH is the most widely employed carrier protein for this purpose. KLH is an effective carrier protein for several reasons. Its large size and numerous epitopes generate a substantial immune response, and abundance of lysine residues for coupling haptens allows a high hapten:carrier protein ratio, increasing the likelihood of generating hapten-specific antibodies. In addition, because KLH is derived from the limpet, a gastropod, it is phylogenetically distant from mammalian proteins, thus reducing false positives in immunologically based research techniques in mammalian model organisms. KLH can also be a challenging molecule to work with because of its propensity to aggregate and precipitate. Aggregates remain immunogenic, but limit the ability to conjugate haptens, and are difficult to manipulate in the laboratory. A high-quality KLH preparation with clear opalescent blue color is the best indicator of KLH solubility.
===== Europe ===== Belgium - DMT cannot be possessed, sold, purchased or imported. Usage is not specifically prohibited, but since usage implies possession one could be prosecuted that way. France - DMT, along with most of its plant-sources, is classified as a stupéfiant (narcotic). Germany - DMT is prohibited as a class I drug. Ireland - DMT is an illegal Schedule 1 drug under the Misuse of Drugs Acts. An attempt in 2014 by a member of the Santo Daime church to gain a religious exemption to import the drug failed. Latvia - DMT is prohibited as a Schedule I drug. Netherlands - The drug is banned as it is classified as a List 1 Drug per the Opium Law. Production, trade and possession of DMT are prohibited. Serbia - DMT, along with stereoisomers and salts is classified as List 4 (Psychotropic substances) substance according to Act on Control of Psychoactive Substances. Sweden - DMT is considered a Schedule 1 drug. The Swedish supreme court concluded in 2018 that possession of processed plant material containing a significant amount of DMT is illegal. However, possession of unprocessed such plant material was ruled legal. United Kingdom - DMT is classified as a Class A drug.
In July 2023, the Biden administration secured voluntary commitments from seven companies – Amazon, Anthropic, Google, Inflection, Meta, Microsoft, and OpenAI – to manage the risks associated with AI. The companies committed to ensure AI products undergo both internal and external security testing before public release; to share information on the management of AI risks with the industry, governments, civil society, and academia; to prioritize cybersecurity and protect proprietary AI system components; to develop mechanisms to inform users when content is AI-generated, such as watermarking; to publicly report on their AI systems' capabilities, limitations, and areas of use; to prioritize research on societal risks posed by AI, including bias, discrimination, and privacy concerns; and to develop AI systems to address societal challenges, ranging from cancer prevention to climate change mitigation. In September 2023, eight additional companies – Adobe, Cohere, IBM, Nvidia, Palantir, Salesforce, Scale AI, and Stability AI – subscribed to these voluntary commitments. In January 2023, the NIST released the Artificial Intelligence Risk Management Framework (AI RMF 1.0), providing voluntary guidance for organizations to identify, assess, and manage risks associated with AI systems. The Biden administration, in October 2023 signaled that they would release an executive order leveraging the federal government's purchasing power to shape AI regulations, hinting at a proactive governmental stance in regulating AI technologies.
== History == The center was conceived in 2006. Construction began in 2013 after securing funding from the European Regional Development Fund (ERDF) and Czech state grants, with the facility opening in phases between 2015-2016. During the COVID-19 pandemic, BIOCEV’s laboratories were repurposed for PCR testing for regional health authorities. In 2021, the original legal entity (BIOCEV z.s.p.o.) was dissolved, though research operations continued under CAS and Charles University management.
=== SIRV model === The Susceptible-Infectious-Recovered-Vaccinated model is an extended SIR model that accounts for vaccination of the susceptible population. This model uses the following system of differential equations:
Sources: en.wikipedia.org
意味着单个分子可同时结合三种代谢受体,而不是只作用于一种。其目的是整合食欲、胰岛素和能量消耗通路,但人体中的协同程度仍在研究。
不是。研究还评估血糖控制、肝脏脂肪、血脂和心血管风险标志物。不同终点的证据成熟度不同。
胰高血糖素成分在人体中的净效应存在争议,因为它可能升高血糖,也可能增加能量消耗。长期平衡和个体差异尚未明确。
Purity is normally given as a percentage from reversed-phase HPLC, calculated as the main peak area relative to total peak area. Research-grade material is commonly specified at 95 per cent or higher, with tighter specifications available. The number is method-dependent and should be read alongside the chromatogram.